SABIC Q2 Net Income Surges to SAR 500 Million on 3 Percent Sales Rise Board Approves SAR 4.5 Billion Dividend
SABIC, the global diversified chemical leader, posted an adjusted net income of SAR 500 million (about RMB 960 million) for the second quarter of 2025, a sharp turnaround from a SAR 100 million loss in Q1—an improvement of SAR 555 million. Quarterly sales climbed to SAR 35.6 billion (RMB 68.1 billion), up 3% from the previous quarter, while total product volume reached 11.78 million tons, also up 3%.
Increased licensing and engineering service revenues helped offset a decline in average product prices. The company’s health, safety, and environment incident rate dropped to 0.07 in H1, marking the lowest level in a decade and outperforming global industry standards.
At the Riyadh Q2 briefing, CEO Al-Fageeh announced a SAR 4.5 billion interim dividend for H1 2025, highlighting SABIC’s focus on maximizing shareholder returns and maintaining robust financial health. The Board also discussed ongoing business transformation, including the closure of the UK Teesside cracker and strategic options for the Saudi National Industrial Gases Company, such as a potential IPO.
SABIC’s subsidiary, Arabian Petrochemical Company, is progressing with its 1 million ton/year MTBE project—over 95% completed and set for trial operation in Q3 2025. Meanwhile, the Fujian integrated petrochemical complex in China is advancing steadily, underpinning SABIC’s growth ambitions in Asia.
Al-Fageeh reiterated the company’s commitment to operational efficiency, sustainable value, and long-term resilience, as SABIC continues to enhance its business model for future growth and competitiveness.
2026-10-17
Trade Alert
Delivering the latest product trends and industry news straight to your inbox.
(We'll never share your email address with a third-party.)
Related News
-
Procter & Gamble Posts Higher Profits on Strong Personal Care Sales and Recovery in China
-
Huntsman Issues Two Consecutive MDI Price Hike Notices: €250 Increase in Europe, $300 Increase in India
-
Lotte Chemical Plans Sale of Selected Operations in Malaysia, Indonesia, and the United States
-
Dover to Acquire Cloeren and Expand Its Polymer-Extrusion Equipment Portfolio
-
GACL Approves Additional Hydrochloric Acid Unit at Dahej
-
Croda’s First-Half Profit Outpaces Sales as Beauty Actives Grow 19%
-
argenx to Acquire Forte Biosciences for $2.2 Billion in Major Autoimmune Antibody Deal
-
Advent Drops Its 2026 Purchase, and LANXESS’s €1.2 Billion Exit Plan Falls Through
-
Wanhua Chemical Establishes a RMB 1.488 Billion New Energy Materials Company in Weifang, Further Integrating Green Power and Battery Materials Businesses
-
BASF Moves to Sell 4,400 Employee Homes—Union Fury Reveals the Survival Math of a Chemical Giant
Recommend Reading
-
Merck Nears Acquisition of Cidara to Strengthen Flu Prevention Arsenal
-
Biocon Weighs Merger of Biocon Biologics to Unlock Value
-
BASF and Encina Bet on Circular Chemical Feedstocks
-
Roche Keeps German Diagnostics Investment
-
Shin-Etsu Chemical Invests $218 Million in Rare Earth Refinery as Multiple Countries Accelerate Domestic Production
-
Supply Eases, ABS Prices Reduced in Early December in China
-
Phosphate prices slightly increase in China (12.5-12.11)
-
Sulfate of Ammonia Market Stably Operates (12.5-12.11)
-
June 8th: Shandong Asphalt Supply Declines, Market Continues to Rise
-
Supply Pressure Doubles, Hydrogen Peroxide Prices Continue to Fall in China